Scinovex
Subscribe
J

Jens J. Holst

Novo Nordisk FoundationORCID https://orcid.org/0000-0001-6853-3805
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

The Physiology of Glucagon-like Peptide 1
Physiological Reviews20073,192 citationsFirst authorCorresponding
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Journal of Clinical Investigation19931,635 citations
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
Diabetologia19931,087 citations
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Cell Metabolism2017980 citations
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
American Journal of Physiology-Endocrinology and Metabolism1997816 citations
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Digestive Diseases and Sciences1993670 citations
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
American Journal of Physiology-Endocrinology and Metabolism2004667 citations
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
American Journal of Physiology-Endocrinology and Metabolism2004608 citationsFirst authorCorresponding
The incretin system and its role in type 2 diabetes mellitus
Molecular and Cellular Endocrinology2008509 citationsFirst authorCorresponding
The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon
American Journal of Physiology-Gastrointestinal and Liver Physiology2018379 citationsCorresponding
Antihyperglycemic effects of stevioside in type 2 diabetic subjects
Metabolism2003375 citations